[The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]

Related Experiment Video

Updated: May 15, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
04:38

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

S K Erkebaeva, E S Nurguzhaev, B G Gafurov

    Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
    |December 22, 2012
    PubMed

    Insights

    Cytoflavin improved neurological symptoms and cognitive functions in patients with discirculatory encephalopathy and depression. This treatment may prevent cerebrovascular disease progression and stroke.

    Area of Science:

    • Neurology
    • Pharmacology

    Context:

    • Discirculatory encephalopathy (DE) and depressive syndrome are common in patients with arterial hypertension.
    • Standard treatments may not fully address neurological and depressive symptoms.

    Purpose:

    • To evaluate the clinical efficacy of cytoflavin in patients with discirculatory encephalopathy (DE) and depressive syndrome associated with arterial hypertension.
    • To assess the impact of cytoflavin on neurological symptoms, cognitive functions, and depression severity.

    Summary:

    • Cytoflavin, administered intravenously and orally for 35 days, showed significant improvements in neurological symptoms and subjective disorders compared to placebo.
    • Patients receiving cytoflavin demonstrated enhanced attention, reasoning, speech, and memory restoration.
    • The efficacy of cytoflavin in alleviating depression was more pronounced in cases of mild depression, with a notable reduction in severity for moderate and severe cases.

    Impact:

    • Cytoflavin may be recommended for managing DE with depressive syndrome in hypertensive patients.
    • It shows potential as a preventive medication against cerebrovascular pathology progression and stroke development.
    • The findings suggest a beneficial role for cytoflavin in improving cognitive and mood disturbances associated with vascular conditions.

    Related Concept Videos

    Electroconvulsive Therapy01:30

    Electroconvulsive Therapy

    Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    Ischemic Stroke l: Introduction01:15

    Ischemic Stroke l: Introduction

    Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Hemorrhagic Stroke l: Introduction01:17

    Hemorrhagic Stroke l: Introduction

    A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...